When drawing up a list of which Trump nominees are likely to spark confirmation fights on Capitol Hill, keep Mehmet Oz near the top.

Mehmet Oz, a celebrity heart surgeon turned talk show host and lifestyle guru, is President-elect Donald Trump’s pick to run the Centers for Medicare and Medicaid Services, the massive federal health care bureaucracy that covers more than a third of Americans.

President-elect Donald Trump has picked Dr. Mehmet Oz to serve as the administrator for the Centers for Medicare and Medicaid Services, a key federal agency that oversees health insurance coverage for more than 150 million Americans.

President-elect Donald Trump has tapped several TV personalities for key posts in his incoming administration, including Dr. Mehmet Oz to run the Centers for Medicare and Medicaid Services, an agency that oversees health coverage for 150 million people.

Dr. Mehmet Oz, the celebrity heart surgeon from New Jersey who hosts TV's Dr. Oz Show, was given a position by President-elect Donald Trump.

Trump will nominate the former Senate candidate to oversee major healthcare programs like Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Affordable Care Act.

Oz used his TikTok page on multiple occasions in November to praise Trump and Robert F. Kennedy Jr., including their efforts to take on the “illness-industrial complex,” and he slammed “so-called experts like the big medical societies” for dishing out what he called bad nutritional advice.

Dr. Mehmet Oz could hold millions of dollars in investments in companies regulated by the federal agency Donald Trump has tapped him to lead. During his failed Senate run in 2022, the former talk show host reported tens of millions of dollars in investments in health care,

Dr. Oz holds a plethora of investments in healthcare, pharmaceutical, health insurance and health research companies

Dr. Mehmet Oz — who Donald Trump nominated last week to lead the Centers for Medicare and Medicaid Services (CMS — holds "stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the healthcare sector,